Aducanumab and adenoviral COVID-19 vaccines: increased cerebral hemorrhage risk? Editorial Material

MohanaSundaram, ArunSundar, Thukani Sathanantham, Shanmugarajan, Sveikata, Lukas et al. (2022). Aducanumab and adenoviral COVID-19 vaccines: increased cerebral hemorrhage risk? . EXPERT REVIEW OF NEUROTHERAPEUTICS, 22(4), 283-286. 10.1080/14737175.2022.2053112

cited authors

  • MohanaSundaram, ArunSundar; Thukani Sathanantham, Shanmugarajan; Sveikata, Lukas; Lalla, Rakesh Shyam; Sveikatienė, Renata; Kaushik, Ajeet; Velayutham, Ravichandiran

authors

publication date

  • April 1, 2022

published in

keywords

  • Alzheimer Disease
  • Amyloid beta-Peptides
  • Antibodies, Monoclonal, Humanized
  • COVID-19
  • COVID-19 Vaccines
  • Cerebral Hemorrhage
  • Humans

Digital Object Identifier (DOI)

Medium

  • Print-Electronic

start page

  • 283

end page

  • 286

volume

  • 22

issue

  • 4